Aster DM Healthcare Ltd Share Price

Q: What is the share price of Aster DM Healthcare Ltd today?

Aster DM Healthcare Ltd share price as on 18 Nov 2025 is ₹697.25

Healthcare

NSE: ASTERDM Small Cap ISIN: INE914M01019

As on 18 November 2025 at 23:52 IST

₹697.25

+ 18.15

(2.67%)

Sell Buy

Aster DM Healthcare Q1 FY26 Results:

Profit for the period declined 98.2% to ₹93.6 crores in Q1 FY26, from ₹5,152.2 crores in Q1 FY25. Total income for the quarter increased 5.8% year-on-year to ₹1,111.1 crores, from ₹1,050.6 crores.

About Aster DM Healthcare Ltd

Aster DM Healthcare Ltd is a prominent multinational healthcare provider. The company operates a network of hospitals and pharmacies across the Middle East, India, and the Philippines. The corporate headquarters of Aster DM Healthcare is located in Dubai, United Arab Emirates. It has been in business since 1987, making it a well-established player with decades of experience in the industry. Aster DM Healthcare’s primary products and services include hospital care, diagnostic services, and pharmacy operations. The company is known for its commitment to providing high-quality, affordable healthcare services to a broad demographic. +

Over 1 Month

-3.32%

Over 6 Months

16.25%

Over 1 Year

57.80%

Over 3 Years

206.11%

Aster DM Healthcare Ltd Summary

Close ₹679.10

Open ₹676

High ₹684.15

Low ₹667.35

Volume 5,11,981

Net Turnover (in Cr) ₹34.6

52Wk High ₹732.20

52Wk Low ₹387.10

52Wk High / Low

387.10

732.20

Aster DM Healthcare Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹35,185.60

EPS (TTM) 6.52

Book Value (BV) 84.56

Div. Yield 0.71 %

P/E (TTM) 118.80

Price/Book Value 8.02

Delivery % 51.28 %

Face Value 10

Key Ratios

PE Ratio 3.90

PB Ratio 8.32

EV to Sales 10.40

PEG Ratio 0

ROA 135.26

ROE 214.94

Debt-Equity 0.31

Net Profit Margin 267.57

Operating Profit Margin 281.15

Aster DM Healthcare Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	4,286.69	3,723.75	3,030.95	10,303.94	8,658.40
Total Expenses	3,746.58	3,451.22	2,824.27	9,667.63	8,456.87
Profit Before Tax	471.06	261.19	195.46	636.85	205.05
Profit After Tax	336.69	204.68	159.59	601.05	177.83
Operating Profit After Depreciation	663.92	382.83	293.94	893.33	495.19

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	3,922.27	3,175.39	9,076.28	7,028.70	6,748.93
Total Non Current Assets	4,704.91	3,826.01	9,959.64	8,449.78	8,014.45
Total Current Assets	1,901.47	14,165.30	4,921.56	4,096.46	3,629.01
Total Assets	6,606.38	17,991.31	14,881.20	12,546.24	11,643.46
Total Shareholder's Fund	3,428.07	4,559.79	4,448.07	3,953.41	3,372.46

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	425.05	157.81	1,833.98	1,314.04	1,569.12
Net Cash Used In Investing Activities	6,015.12	-878.25	-950.85	-563.26	-333.09
Net Cash Used In Financing Activities	-6,357.81	1,052.83	-817.39	-686	-1,116.13

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	8,059.15	2,085.52	1,583.51	1,198.67	768.17
Total Expenses	2,094.05	1,876.17	1,401.18	1,108.71	836.21
Profit Before Tax	6,288.25	209.35	182.33	89.96	-68.04
Profit After Tax	6,208.97	156.96	173.29	90.18	-68.78
Operating Profit After Depreciation	6,050.67	287.72	234.14	133.98	-31.54

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	1,760.44	1,333.01	1,008.31	1,013.26	1,010.49
Total Non Current Assets	3,353.14	2,767.89	3,787.19	3,562.22	3,390.37
Total Current Assets	1,611.62	1,769.84	314.88	199.78	198.25
Total Assets	4,964.76	4,537.73	4,102.07	3,762	3,588.62
Total Shareholder's Fund	3,339.49	3,294.24	3,130.56	2,955.21	2,864.11

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	367.23	412.75	245.86	78.34	41.66
Net Cash Used In Investing Activities	6,023	-342.32	-331.95	-49.17	-38.07
Net Cash Used In Financing Activities	-6,298.11	-67.09	92.20	-17.69	-12.35

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	1,197.21	1,077.87	1,000.34	1,049.81	1,086.44
Total Expenses	961.37	876.23	818.28	864.22	869.30
Profit Before Tax	166.85	136.44	90.54	101.88	158.65
Profit After Tax	121.31	93.56	85.54	64.39	105.76
Operating Profit after Depreciation	264.09	234.82	213.34	218.58	252.38

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	681.81	613.04	573.86	576.32	604.68
Total Expenses	532	479.53	458.96	465.05	475.68
Profit Before Tax	132.43	108.03	62.60	68.33	119.83
Profit After Tax	104.61	80.59	61.07	49.82	89.84
Operating Profit after Depreciation	194.45	171.94	150.03	148.56	175.74

Aster DM Healthcare Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 669.58

S2 660.07

S3 652.78

Pivot 676.87

R1 686.38

R2 693.67

R3 703.18

Moving Average

20 SMA 693.09

50 SMA 667.20

100 SMA 634.35

200 SMA 564.32

Aster DM Healthcare Ltd Corporate Actions

Aster DM Healthcare Ltd

₹1.0/Share

Announcement Date 28 Aug 2025

Record Date 28 Aug 2025

Div Yield 10%

AGM Date: 13 Aug 2021

AGM 13/08/2021 With reference to captioned subject, we wish to inform that the 13th AGM of Aster DM Healthcare Limited ('the Company') is scheduled to be held on Friday, August 13, 2021 at 11:30 A.M (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') to transact the businesses as set forth in the Notice of AGM. Pursuant to Regulation 34 of the SEBI (LODR) Regulations, 2015, please find enclosed the Notice of the 13th Annual General Meeting and the Annual Report for the financial year 2020-21. In compliance with the MCA Circulars and SEBI Circulars the Notice of the 13th AGM along with the Annual Report for the FY 2020-21 are being sent only through electronic mode to those Members whose email IDs are registered with the Company/ Depositories. Further, the same are also made available on the website of the Company at www.asterdmhealthcare.com/investors/. We request you to take the same on record. (As per BSE Announcement Dated on 21/7/2021) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the 13th Annual General Meeting (AGM) of the Company was held on August 13, 2021 through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM') and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the proceedings of AGM in compliance with the provisions of aforesaid regulations. We request you to kindly take on record the above information. (As per BSE Announcement Dated on 13/8/2021) Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the 13th Annual General Meeting (AGM) of the Company was held on August 13 2021 through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM) and the business mentioned in the Notice convening the AGM were transacted. In this regard please find enclosed the following: 1. Submission of voting results in compliance with the provisions of regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- I. 2. Report of Scrutinizer dated August 14 2021 in compliance with the provisions of section 108 of the Companies Act 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules 2014 as Annexure - II. We request you to kindly take on record the above information. Aster DM Healthcare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated on 8/14/2021)

AGM Date: 25 Aug 2022

AGM 25/08/2022 Pursuant to Regulation 30 and 47 of SEBI Listing Regulations, please find enclosed the copies of newspaper advertisement published on July 30, 2022, in Financial Express (English Language) and Vijayavani (Kannada Language), in compliance with Ministry of Corporate Affairs Circulars intimating that 14th Annual General Meeting of the Company will be held on Thursday, August 25, 2022 at 11:30 AM (IST) through Video Conferencing / Other Audio Visual Means. The above information will also be available on the website of the Company at https://www.asterdmhealthcare.com/investor/stock exchange-disclosures . We request you to kindly take the same on record (As Per BSE Announcement Dated on 30/07/2022) With reference to captioned subject, we wish to inform you that the 14th Annual General Meeting ('AGM') of Aster DM Healthcare Limited ('the Company') is scheduled to be held on Thursday, August 25, 2022 at 11:30 A.M. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'), in compliance with applicable circulars issued by the Ministry of Corporate Affairs ('MCA circulars'), the Securities and Exchange Board of India ('SEBI circulars') and other applicable provisions of the Companies Act, 2013, to transact the businesses as set forth in the Notice of AGM. Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed the Notice of the 14th AGM and the Integrated Annual Report for the financial year 2021-22. Please find enclosed copies of newspaper advertisements titled Notice of 14th Annual General Meeting that appeared in today's edition in Financial Express (English Language) and Vijayavani (Kannada Language). This information will also be made available on our website, at the following link: https://www.asterdmhealthcare.com/investor/stock exchange-disclosures . We request you to take the same on record. (As Per BSE Announcement dated on 03.08.2022) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 14th Annual General Meeting (AGM) of the Company was held on Thursday, August 25, 2022 at 11:30 a.m. through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM') and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the proceedings of AGM in compliance with the provisions of aforesaid regulations. Kindly take the above said information on record. (As Per BSE Announcement Dated on 25.08.2022) Aster DM Healthcare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated 29.08.2022) Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 14th Annual General Meeting (AGM) of the Company was held on August 25, 2022 through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM') and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the following: 1. Submission of voting results in compliance with the provisions of regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure- I 2. Report of Scrutinizer dated August 27, 2022 in compliance with the provisions of section 108 of the Companies Act, 2013 and Rule 20(4)(xii) of the Companies (Management and Administration), Rules 2014 as Annexure - II We request you to kindly take on record the above information. (As Per BSE Announcement Dated on 27.08.2022) Please find enclosed herewith the transcript of the 14th Annual General Meeting of the Company held on August 25, 2022. The same is also made available on the website of the Company at https://www.asterdmhealthcare.com/investor/shareholders-services Kindly take the above said information on record. (As Per BSE Announcement Dated on 30/08/2022)

AGM Date: 31 Aug 2023

Pursuant to Regulation 30 and 47 of SEBI Listing Regulations, please find enclosed the copies of newspaper advertisement published on August 04, 2023, in Financial Express (English Language) and Vijayavani (Kannada Language), in compliance with Ministry of Corporate Affairs Circulars intimating that 15th Annual General Meeting of the Company will be held on Thursday, August 31, 2023 at 11:30 AM (IST) through Video Conferencing /Other Audio Visual Means. With reference to captioned subject, we wish to inform you that the 15th Annual General Meeting (AGM) of Aster DM Healthcare Limited (the Company) is scheduled to be held on Thursday, August 31, 2023 at 11:30 AM (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM), in Compliance with applicable circulars issued by the Ministry of Corporate Affairs (MCA Circulars), the Securities and Exchange Board of India (SEBI Circulars) and other applicable provisions of the Companies Act, 2013, to transact the businesses as set forth in the Notice of AGM. (As per BSE Announcement Dated on 08/08/2023) With reference to captioned subject, we wish to inform you that the 15th Annual General Meeting (AGM) of Aster DM Healthcare Limited (''the Company'') is scheduled to be held on Thursday, August 31, 2023 at 11:30 AM (IST) through Video Conferencing (VC) /Other Audio Visual Means (OAVM), in compliance with applicable circulars issued by the Ministry of Corporate Affairs (MCA circulars), the Securities and Exchange Board of India (SEBI circulars) and other applicable provisions of the Companies Act, 2013, to transact the businesses as set forth in the Notice of AGM. The Notice of the 15th AGM and Integrated Annual Report for the financial year 2022-23 has been sent on August 08, 2023, only through electronic mode to those Members whose email IDs are registered with the Company /Depositories as on Friday, August 04, 2023. (As Per BSE Announcement Dated on 09.08.2023) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 15th Annual General Meeting (AGM) of the Company was held on Thursday, August 31, 2023 at 11:30 AM (IST) through Video Conferencing (''VC'')/ Other Audio-Visual Means (''OAVM'') and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the proceedings of AGM in compliance with the provisions of aforesaid regulations. (As Per BSE Announcement dated on 31.08.2023) Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the 15th Annual General Meeting (''AGM'') of the Company was held on Thursday, August 31, 2023 through Video Conferencing (''VC'') / Other Audio-Visual Means (''OAVM'') and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the following: 1. Submission of voting results in compliance with the provisions of Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 2. Report of Scrutinizer dated September 01, 2023 in compliance with the provisions of Section 108 of the Companies Act, 2013 and Rule 20(4) (Xii) of the Companies (Management and Administration) Rules, 2014 (As per BSE Announcement Dated on 01/09/2023)

AGM Date: 29 Aug 2024

AGM 29/08/2024 With reference to the above captioned subject, Please be informed that the Board of Directors at their meeting held on 28th May, 2024 have inter alia approved the convening of 16th Annual General Meeting of the Company on Thursday, 29th August, 2024 through video conference and/or other audio visual means. (As Per BSE Announcement dated on 28.05.2024) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 16th Annual General Meeting (AGM) of the Company was held on Thursday, August 29, 2024 at 11.30 AM (IST) through Video Conferencing or other Audio - Visual Means and the business mentioned in the Notice convening the AGM were transacted. In this regard, please find enclosed the proceedings of the AGM in compliance with the provisions of aforesaid regulations. (As Per BSE Announcement dated on 29.08.2024) Pursuant to Regulation 44 of the SEBI (LODR) Regulations, 2015, we wish to inform that the 16th Annual General meeting (AGM) of the Company was held on Thursday, August 29, 2024 through Video conferencing/ Other Audio- Visual Means and the business mentioned in the Notice convening the AGM were transacted. All the resolutions were passed with requisite majority. In this regard, please find enclosed the following: 1. Submission of voting results in compliance with the provisions of Regulation 44 of the SEBI (LODR) Regulations, 2015. 2. Report of Scrutinizer dated August 30, 2024 in compliance with the provisions of Section 108 of the Companies Act, 2013. We request you to kindly take the same on record. (As per BSE Announcement Dated on 30/08/2024)

AGM Date: 04 Sep 2025

The 17th Annual General Meeting ('17th AGM') of the Company shall be held on Thursday, September 04, 2025, at 11.30 AM (IST) through Video Conferencing / Other Audio Visual Means. Notice of 17th Annual General Meeting is enclosed (As Per BSE Announcement Dated on 12.08.2025) Proceedings of 17th Annual General Meeting held on 4th September 2025 (As per BSE Announcement Dated on 04/09/2025) Voting results and Scrutinizer''s report of the 17th AGM held on 4th September 2025 (As per BSE Announcement Dated on 05.09.2025) We enclose herewith copy of transcript of 17th Annual General Meeting of the Company held on September 4, 2025, at 11:30 a.m. IST through Video Conferencing (As Per BSE Announcement Dated on 10.09.2025)

Aster DM Healthcare Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Max Healthcare Institute Ltd	₹1,121.90	₹1,09,099.45
Apollo Hospitals Enterprise Ltd	₹7,488.40	₹1,07,671.70
Fortis Healthcare Ltd	₹944.15	₹71,279.37
Narayana Hrudayalaya Ltd	₹2,027.90	₹41,442.33
Global Health Ltd	₹1,204.20	₹32,367.74

Aster DM Healthcare Ltd Top Mutal Funds Invested

Fund Name	AUM
Kotak Small Cap Fund	4.42%
HDFC Small Cap Fund	4.22%
Franklin India Small Cap Fund	2.76%
Quant Small Cap Fund	2.51%
HDFC Children's Fund	2.42%

Aster DM Healthcare Ltd News

Aster DM Healthcare announces board meeting date

On 6 November 2025

31 Oct 2025, 04:25 pm

Aster DM Healthcare appoints Chief Information Officer & Chief Information Security Officer

With effect from 01 August 2025

01 Aug 2025, 01:46 pm

Aster DM Healthcare to hold AGM

On 4 September 2025

01 Aug 2025, 10:05 am

Aster DM Healthcare to hold board meeting

On 30 July 2025

26 Jul 2025, 10:07 am

Aster DM Healthcare Ltd leads gainers in 'A' group

Rategain Travel Technologies Ltd, Motilal Oswal Financial Services Ltd, Honeywell Automation India Ltd and Jai Balaji Industries Ltd are among the other gainers in the BSE's 'A' group today, 03 July 2025.

03 Jul 2025, 12:00 pm

Aster DM Healthcare Ltd Stock Analysis

Annual revenue for Aster DM Healthcare Ltd increased by 286.43% to ₹8,059.15 crore in FY 2025 from ₹2,085.52 crore in FY 2024.
Annual Net Profit for Aster DM Healthcare Ltd increased by 3855.77% to ₹6,208.97 crore in FY 2025 from ₹156.96 crore in FY 2024.
Promoter Shareholding in Aster DM Healthcare Ltd increased by 0.01% in the most recent quarter, from 40.39% in June 2025 to 40.39% in September 2025.
Aster DM Healthcare Ltd delivered a 1-year return of 57.80% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Aster DM Healthcare Ltd share price moved up by 2.67% from its previous close of INR ₹679.10. The latest Aster DM Healthcare Ltd share price is INR ₹697.25.
Aster DM Healthcare Ltd share price today has been at a low of 683 and a high of 714. Over the past 52 weeks, the Aster DM Healthcare Ltd share price has seen a low of 387.10 and a high of 732.20.

About Aster DM Healthcare Ltd

Aster DM Healthcare Ltd is a prominent multinational healthcare provider. The company operates a network of hospitals, clinics, and pharmacies across the Middle East, India, and the Philippines. It offers various healthcare services, including primary, secondary, and tertiary care. The company also provides advanced medical treatments and diagnostic services.
Aster DM Healthcare falls under the healthcare sector, specifically within the hospital and healthcare services sub-sectors. The company has been in business since 1987, making it a well-established player with decades of experience in the industry.
The corporate headquarters of Aster DM Healthcare is located in Dubai, United Arab Emirates. Key promoters of the company include Union Investments Private Limited, with a 37.41% stake in the company. A team of professional managerial promoters manages the operations of the company-

Azad Moopen
Alisha Moopen
Daniel Robert Mintz
T J Wilson
Shamsudheen Bin Mohideen Mammu Haji

Aster DM Healthcare’s primary products and services include hospital care, outpatient services, diagnostic services, and pharmacy operations. The company is known for its commitment to providing high-quality healthcare services. It also focuses on affordability, ensuring access for a broad demographic.
While Aster DM Healthcare is a significant player in the healthcare sector, it is not currently the largest in market share or market cap. However, it is a well-respected and influential entity within its industry.
The registered office of Aster DM Healthcare is in Bengaluru, Kerala, and the registrar's office is in Mumbai, Maharashtra. Aster DM Healthcare Ltd is a well-established healthcare provider with a strong presence in the Middle East and India. Founded by Dr. Azad Moopen, the company offers a wide range of healthcare services and continues to grow under his leadership.

Impact of Aster DM Healthcare Limited

Aster DM Healthcare Ltd has significantly impacted the healthcare landscape. Its influence is particularly notable in the Middle East and India. Founded in 1987 by Dr. Azad Moopen, the company has grown into a primary healthcare provider. It offers a wide range of services through its network of hospitals and pharmacies. The company’s commitment to quality and affordable healthcare has transformed the lives of millions of people.
One of the most notable impacts of Aster DM Healthcare is its ability to provide accessible healthcare services. Aster has established state-of-the-art hospitals and clinics in regions where medical facilities were once scarce. This expansion has ensured that people in remote and underserved areas access essential medical care. The company’s presence in these regions has reduced the need for patients to travel long distances for treatment. This change has helped save both time and money for those seeking healthcare.
Aster DM Healthcare has also played a crucial role in improving the quality of healthcare services. The company invests heavily in advanced medical technology and equipment, ensuring its facilities are equipped with the latest tools for diagnosis and treatment. As a result, patients receive better care and have higher chances of recovery.
Its emphasis on training and development has positively impacted the healthcare workforce. Aster provides continuous education and training programs for its medical staff. It ensures that they stay updated with the latest advancements in medical science. This commitment has led to a highly skilled and knowledgeable workforce. As a result, they can deliver high-quality care to patients and improve health outcomes. The presence of well-trained healthcare professionals has improved patient outcomes. It has also increased overall patient satisfaction with the care they receive.
Aster DM Healthcare’s focus on affordability has made healthcare accessible to a broader population. The company offers various healthcare packages and insurance plans that cater to different income groups. This approach has enabled people from diverse economic backgrounds to access quality medical care without financial strain. The affordability of Aster's services has encouraged more people to seek medical attention early. This proactive approach leads to better health outcomes and reduces healthcare costs in the long run.
The company’s impact extends beyond direct patient care. Aster DM Healthcare is actively involved in community outreach and health awareness campaigns. These initiatives aim to promote healthy lifestyles. Raising awareness about common health issues has contributed to the overall well-being of the communities it serves. These efforts have helped reduce the incidence of chronic diseases and improved public health.
Aster DM Healthcare’s commitment to corporate social responsibility (CSR) has enhanced its impact. The company undertakes various CSR activities, including free medical camps and support for underprivileged communities. These initiatives have provided essential medical assistance to those who cannot afford it. As a result, they have significantly improved the quality of life for many individuals. Aster’s CSR efforts reflect its dedication to giving back to society and making a positive difference.
The company’s growth and expansion have also had economic benefits. Aster DM Healthcare has created numerous job opportunities in the regions it operates. Establishing new hospitals and clinics has created jobs for medical professionals and support personnel. This employment generation has contributed to the economic development of these regions and improved the standard of living for many families.